Scale Labs
research lab/company
Executable agent benchmarks, human-feedback research, data, safety, and evaluation.
AI Thought Leadership · Topic 8 of 11
Recent programs emphasize integrated scientific work: agent-assisted scientific software, AI workbenches, multi-step drug-discovery evaluation, and design engines that go beyond structure prediction. The historical through-line runs from expert systems, through machine discovery and inductive…
Current through September 18, 2026
Editorial provenance
Recent programs emphasize integrated scientific work: agent-assisted scientific software, AI workbenches, multi-step drug-discovery evaluation, and design engines that go beyond structure prediction. The historical through-line runs from expert systems, through machine discovery and inductive logic programming, to robot scientists that select and execute experiments.
The key boundary is epistemic: generating a molecule, proof sketch, hypothesis, or code change is not the same as establishing a scientific result. A credible workflow preserves provenance, compares baselines, represents uncertainty, records negative evidence, and submits the claim to a measurement that could be wrong.
Scientific learning can be framed as choosing an experiment e that is expected to reduce uncertainty about hypothesis H. Expected information gain is
EIG(e) = E_y[ KL(P(H|y,e) || P(H)) ],
where y is the possible result and KL measures how much the posterior differs from the prior.
Worked example: suppose two hypotheses have prior probabilities (0.5,0.5). An experiment has outcomes that are 90 percent likely under H1 and 10 percent under H2. If the positive outcome occurs, Bayes' rule gives posterior P(H1|+) = .9. Entropy falls from 1 bit to about 0.469 bits; the result provides about 0.531 bits of information. A more discriminating experiment has higher expected information gain, but cost and risk must also be considered.
The experiment-selection utility can be U(e)=EIG(e)-λ·cost(e)-ρ·risk(e). This makes the tradeoff explicit; the weights are decisions, not facts supplied by the model.
Objective: reproduce hypothesis selection, experiment choice, observation, and update on a transparent synthetic system.
Environment: simulate bacterial growth from two candidate mechanisms, or use a simple physical law with hidden parameters. Expose a finite menu of experiments with different costs and noise. Keep a hidden ground truth for evaluation.
Procedure: define priors over hypotheses; compute predicted outcome distributions; select experiments using random choice, uncertainty sampling, and expected information gain; sample noisy observations; update by Bayes' rule; stop when posterior confidence or budget threshold is reached. Repeat over 500 simulated worlds.
Metrics: experiments required to identify the true hypothesis, total cost, false-confidence rate, calibration, and robustness when the true mechanism is absent from the hypothesis set.
Expected result: information-gain selection should reduce average experiment count when the model class is correct. All methods may become confidently wrong under model misspecification.
Success criterion: lower cost at matched identification accuracy, plus explicit detection or warning when no hypothesis fits.
Falsification: no advantage over random selection after computation and prior sensitivity are counted.
Safety note: keep the lab simulated. Real biological or chemical experiments require institutional procedures, domain supervision, and applicable safety review.
Claim: workflow-level scientific agents provide more value than isolated predictions because they improve reproducibility and experimental efficiency.
Google DeepMind (opens in a new tab), Isomorphic Labs (opens in a new tab), OpenAI Research (opens in a new tab), Anthropic Research (opens in a new tab), Microsoft Research (opens in a new tab), MIT (opens in a new tab), Allen Institute for AI (opens in a new tab), and relevant university and laboratory groups. Current source artifacts include OpenAI on scientific computing (opens in a new tab), Claude Science (opens in a new tab), DrugDiscoveryBench (opens in a new tab), and IsoDDE (opens in a new tab).
---
Every outbound link in the sections above, listed once. Links open in a new tab.
Inclusion is a monitoring decision, not an endorsement.
research lab/company
Executable agent benchmarks, human-feedback research, data, safety, and evaluation.
research lab/company
Frontier-model safety, interpretability, agents, human-use studies, and system-level trust.
research lab/company
Frontier models, agents, multimodal systems, safety, and AI-for-science programs.
university lab
Major work across agents, robotics, ML systems, HCI, and theory.
publication/index
The main rapid-discovery layer for current AI preprints.
AI-for-science company
Major program in AI-driven drug design and digital biology.
Reviewed items logged for this topic. They support the briefing above; they do not replace it.
Evidence note: Field evidence is informative but not a randomized productivity study.
Evidence note: Single vendor-authored case study on a custom task; gains should not be generalized without replication.
Evidence note: Product announcement; independent evidence of discovery acceleration is not yet established.
Evidence note: LLM-judge scoring and a bounded synthetic environment do not substitute for wet-lab validation.
Evidence note: Conference synthesis combines heterogeneous examples rather than a single comparable evaluation.
Evidence note: Retrospective by the lab's CEO; examples span different systems and evidence bases.
Evidence note: First-party technical report; prospective and independent experimental validation is essential.
Evidence note: arXiv is a preprint index, not peer review; population is modest, the principal window is 24 hours, and clinical deployment has not been established.
Evidence note: Matching a prescribed tail statistic does not by itself prove calibrated probabilities under climate or process shift.
Evidence note: arXiv is a preprint index, not peer review; the benchmark tests execution rather than question selection, programmatic grading can penalize valid alternative analyses, and it inherits ambiguities from source papers.
Evidence note: arXiv is a preprint index, not peer review; the outbreak result covers one pathogen and geography and several baselines and data sources are closely coupled to the proposed system.
Research moves through a repeatable public review cycle: